Levonorgestrel + Ethinyloestradiol Tablets

Product Description

Packing: 1x21 Tablets
Available Strength : 0. 1 Mg + 0.02 Mg

Levonorgestrel + Ethinylestradiol Tablets are a combined oral contraceptive formulation manufactured by Montage Laboratories Pvt. Ltd. Each tablet contains Levonorgestrel, a synthetic progestogen, and Ethinylestradiol, a synthetic estrogen, which work together to prevent ovulation, inhibit fertilization, and alter the uterine lining to reduce the chance of pregnancy.

These tablets are widely used for birth control, regulation of menstrual cycles, and the treatment of hormonal imbalances in women. They may also help manage conditions like dysmenorrhea and polycystic ovarian syndrome (PCOS) under medical supervision.

Montage Laboratories Private Limited

Country/Region:

India
On CPHI since:

2023
Certificates:

3
Employees:

250 - 499

Company types

Manufacturer/Innovator

Pharmaceutical company

Primary activities

Animal Health

Contract Manufacturer

Finished Formulation products Distributor/Buyer

Marketing Services Provider

Nutraceuticals

Pharmaceutical Company (generic finished products)

Compare Add to favorites Added to favorites

Specifications

Details

Product Description: Levonorgestrel + Ethinyl Estradiol Tablets are a combined hormonal contraceptive medication containing two active ingredients: levonorgestrel, a synthetic progestin, and ethinyl estradiol, a synthetic estrogen. These tablets are designed to prevent pregnancy by inhibiting ovulation, thickening cervical mucus to impede sperm penetration, and altering the endometrium to prevent implantation.

Indications and Usage : Levonorgestrel + Ethinyl Estradiol Tablets are indicated for use as a contraceptive to prevent pregnancy in women of reproductive age. They are also used to regulate menstrual cycles and alleviate symptoms of premenstrual dysphoric disorder (PMDD) and moderate acne vulgaris.

Dosage and Administration : The dosage regimen of Levonorgestrel + Ethinyl Estradiol Tablets typically involves taking one tablet daily for 21 consecutive days, followed by a 7-day interval without tablets.